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ABSTRACT
Motivation: A major challenge in utilizing microarray technologies
to measure nucleic acid abundances is ‘normalization’, the goal
of which is to separate biologically meaningful signal from other
confounding sources of signal, often due to unavoidable technical
factors. It is intuitively clear that true biological signal and
confounding factors need to be simultaneously considered when
performing normalization. However, the most popular normalization
approaches do not utilize what is known about the study, both in
terms of the biological variables of interest and the known technical
factors in the study, such as batch or array processing date.
Results: We show here that failing to include all study-speciﬁc
biological and technical variables when performing normalization
leads to biased downstream analyses. We propose a general
normalization framework that ﬁts a study-speciﬁc model employing
every known variable that is relevant to the expression study. The
proposed method is generally applicable to the full range of existing
probe designs, as well as to both single-channel and dual-channel
arrays. We show through real and simulated examples that the
method has favorable operating characteristics in comparison to
some of the most highly used normalization methods.
Availability: An R package called snm implementing the
methodology will be made available from Bioconductor (http://
bioconductor.org).
Contact: jstorey@princeton.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
The microarray technology measures nucleic acid abundances, such
as from mRNA, in biological samples by producing ﬂuorescence
intensities that reﬂect hybridization events between nucleotide
sequences. Attached to the microarray are single-stranded DNA
probes, which represent a short segment of complementary DNA
within a gene. Differences among current microarray technologies
are typically in terms of probe design and the number of
ﬂuorescent dyes applied to any given array. Regardless of the
technology, statistical analysis of these data usually attempts to
∗To whom correspondence should be addressed.
infer the relationship between nucleic acid abundance variation
and biological phenotype. One of the main challenges of this
inference process is normalization, which addresses the fact that
factors not of biological relevance can inﬂuence the observed
intensities (Bolstad et al., 2003; Dudoit et al., 2002; Tseng et al.,
2001; Wu et al., 2004), complicating approaches used to infer
relationships from these data (Dabney and Storey, 2007; Rattray
et al., 2006; Wu and Irrizary, 2007). The major contribution of
this paper is to provide a general ‘supervised’ framework for
microarray normalization (Fig. 1). This approach is applicable to
all major microarray technologies and performs the normalization
in a manner supervised by all known variables relevant to the
study.
Some of the most highly used microarray normalization methods
are what we call ‘unsupervised’ methods. These are normalization
procedures that do not utilize the variables describing the study,
speciﬁcally the biological variables of interest (Fig. 1). For
example, suppose the goal of a microarray study is to identify
genes differentially expressed with respect to an experimental
treatment. Also, suppose that the arrays were processed in two
separate batches. Unsupervised methods ignore the treatment and
batch variables when performing the normalization. However, if
the goal of normalization is to separate biologically meaningful
signal from technical confounders, then it seems infeasible to
do so without taking into account the signal explained by the
study-speciﬁc variables, such as treatment and batch in this
example.
While unsupervised methods may show favorable operating
characteristics in specialized settings—such as when biological
variables contribute relatively negligible signal to the data—it has
been shown they make assumptions about data that are commonly
invalidated in practice (Dabney and Storey, 2007; Irizarry et al.,
2006). As a simple motivating example meant to illustrate how
easily these assumptions are violated, we simulated microarray
data (extensive details are given in following sections) with signal
due to a dichotomous biological variable and intensity-dependent
array effects. We simulated 100000 probes, 30% of which are
differentially expressed. Figure 2 shows the P-value histograms
corresponding to probes, which are not differentially expressed.
Figure2Aisthemethodweproposeinthiswork,wheretheP-values
arecorrectlyUniform(0,1).Figure2CandEshowtheP-valuesfrom
the same probes when using invariant set normalization (ISN; Li
and Wong, 2001) and quantile normalization (QN; Bolstad et al.,
2003), respectively. It can be seen that both sets of P-values are
anti-conservatively biased.
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Fig. 1. A demonstration of the main ideas behind supervised normalization
of microarrays. (A) A hypothetical example to demonstrate the differences
between supervised and unsupervised normalization strategies. The three
boxes arranged across the top display different types of potential effects.
Each of these potentially inﬂuences the unnormalized observed intensities,
which are presented as densities in the middle panel. The blue and red lines
describe the different biological conditions, while the dashed and dotted
lines describe the different dates. The differences among the four arise either
from the biology or study design. After normalization with a supervised
approach that takes all three effects into account when normalizing the
data, the differences between the blue and red lines are still present, while
the differences between the dashed and dotted lines have been removed.
However, for unsupervised approaches, such as quantile normalization, the
resulting data have been transformed so that all arrays have the same
distribution, a result that clearly violates the biological relationship of
interest. (B) An example of the model we ﬁt to the probe-level data from a
microarray study. The model has probe-speciﬁc terms, intensity-dependent
terms and may include other terms such as probe composition effects or
surface level spatial effects.
We show that the main reason for the anti-conservative null
P-value distribution from the two unsupervised normalization
methods is that the known biological variable was not taken into
account. We also show that unsupervised normalization methods
may become more problematic and unpredictable as more study-
speciﬁc variables are ignored. The basic reason for this is that
when performing normalization, one cannot unbiasedly separate
true biological signal from technical and other study-speciﬁc
confounders unless both sets of variables are taken into account
during the normalization process. On the other hand, supervised
normalizationmethods(Bairdetal.,2004;DabneyandStorey,2007;
Fig. 2. Results from simulated data with differential expression and array
effects.Thetrueproportionofnullprobesisπ0 =0.70.(A)P-valuehistogram
of null probes after SNM normalization. (B) P-value histogram of all probes
after SNM normalization. (C) P-value histogram of null probes after QN.
(D) P-value histogram of all probes after QN. (E) P-value histogram of null
probes after ISN. (F) P-value histogram of all probes after ISN.
Wolﬁnger et al., 2001; Wu and Irrizary, 2007; Wu et al., 2004)
use all measured variables as a basis for normalization. Several
supervised methods have been developed for the analysis of dual-
channel microarrays (Baird et al., 2004; Dabney and Storey, 2007;
Wolﬁngeretal.,2001),andrecentworkhasdemonstratedthatresults
from supervised techniques offer a clear improvement over results
obtained from unsupervised approaches (Dabney and Storey, 2007).
However, these methods require highly structured experimental
designs and are not applicable to single-channel microarrays or
microarrays with several probes per gene.
We develop a framework for supervised normalization of
microarray data, which is applicable to a large class of experimental
designs and technologies, including single-channel arrays, dual-
channel arrays and different probe designs (e.g. one probe per
gene, probe sets and exon arrays). We focus the examples on
common sources of confounding variation and demonstrate that
the proposed supervised method accounts for their effects on
the data without perturbing the resulting inference. We provide
examples that show how the framework presented here can be
used to analyze several types of microarray data, thus unifying
the problems of data normalization for these alternative microarray
technologies.
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2 APPROACH
In any given study, there are a set of study-speciﬁc variables
known to the researcher that are also capable of being included
in the model used to perform inference. These study-speciﬁc
variables fall into one of the two categories: biological variables
or adjustment variables. We deﬁne biological variables to be those
whose relationships with nucleic acid variation are the target of
the statistical analysis. The other variables, which are utilized as
covariates to account for other sources of variation, are what we call
adjustment variables. Essentially, adjustment variables are all of the
study-speciﬁc variables not of inferential interest in the study but
may correctly explain variation in the data. These include technical
variables such as dye, surface and probe-composition effects. They
include study design variables, such as batch, technical replicates,
or the dates on which the arrays were processed. Adjustment
variables may also include those that are biological in nature, but
not of interest in the study. For example, perhaps the goal is to
characterize the relationship between an experimental treatment and
gene expression, but the study is performed on both males and
females. If the relationship between sex and expression is not of
interest, then this variable would be included among the adjustment
variables.
The basic idea of the proposed approach and how it differs from
unsupervised methods is displayed in Figure 1. Figure 1A shows
that the proposed normalization approach utilizes all that is known
about the study (biology, study design and technology) in order
to perform the normalization. This allows for the signal due to
biologytobeleftintactinthenormalizeddata.Figure1Bdisplaysan
exampleofthemodelweﬁttotheprobe-leveldatafromamicroarray
study. The model has probe-speciﬁc terms, intensity-dependent
terms and may include other terms such as probe composition
effects or array surface spatial effects. The probe-speciﬁc terms
are partitioned between the biological variables and the adjustment
variables. The intensity-dependent terms are written as smooth,
random functions of these probe-speciﬁc terms. We jointly ﬁt this
model to all probes simultaneously, allowing all relevant variables
to be properly included in the model. Our model ﬁtting procedure is
iterative in order to minimize confounding between the biological
variation of interest and the other sources of variation.
3 METHODS
3.1 A general model
We ﬁrst consider the situation where the complete data from a microarray
experiment consists of three terms: the observed probe intensities,
biological variables and adjustment variables. The intensities are usually
presented as an m×n matrix, Y, where m and n describe the number
of probes and arrays in the entire study, respectively. Deﬁne yij as
the observed intensity for probe i=1,...,m on array j=1,..,n, and yi=
(yi1,yi2,...,yin) as the observed intensities for probe i across the n
arrays. The k-th biological variable for array j, xkj, describes factors
of interest such as disease status, experimental treatment, or time
point. All d covariates for an individual sample j are denoted by the
vector xj, and we group all n such vectors into a d×n matrix X=
(x1,...,xn).
Similarly, the  th adjustment variable for array j, z j, parameterizes
variables to be ﬁt in a probe-speciﬁc manner. Let rc denote the number of
probe-speciﬁc adjustment variables. When the baseline value of yij is not of
interest, this probe-speciﬁc intercept term is included among the adjustment
variables. Deﬁne the vector zj and matrix Z in a fashion analogous to the
one described for xj and X, respectfully. Finally, we assume that there are
rf intensity-dependent effects, which we denote by ftj for effect t=1,...,rf
and array j.
Note that we construct X and Z such that bi=0 represents the case where
the biological variables of interest show no association with probe i. (This is
straightforward to construct even for time course studies; Storey et al. 2005.)
Aconcrete example of X and Z can be found in the Supplementary Material.
We model yij as linear combinations of xj, zj, and intensity-dependent
effects. The model for each probe intensity measurement is written as
yij=
d 
k=1
bikxkj+
rc 
 =1
ai z j+
rf 
t=1
ftj

mij

+eij, (1)
where mij=
d
k=1bikxkj+
rc
 =1ai z j. The coefﬁcients bik and ai  describe
the inﬂuence of the k-th biological and  -th adjustment variable on probe i’s
intensity.Weassumethatthet-thintensity-dependentfunctionftj isarandom
smooth function such that E[ftj(m)|m]=0 for all m. These are parameterized
asNormaldistributedcoefﬁcientsappliedtoaB-splinebasis(Supplementary
Material). The zero expectation can be made without loss of generality
because we allow for probe-speciﬁc offset terms (i.e. intercepts), which
absorb any systematic deviation from these intensity-dependent functions.
Finally, eij is the unexplained random error for probe i on array j with
E[eij]=0.
We can write model (1) for probe i data across all n arrays, yi,a s
yi=biX+aiZ+
rf 
t=1
ft(biX+aiZ)+ei, (2)
where bi and ai are 1×d and 1×rc vectors of the bik and ai  terms in (1),
and ft(biX+aiZ)=

ft1(mi1),...,ftn(min)

. The model for the entire dataset
Y can be written as
Y=BX+AZ+
rf 
t=1
ft(BX+AZ)+E, (3)
where B and A are m×d and m×rc matrices of coefﬁcients, the i-th row
correspondingtobi andai,respectively.Also,ft(BX+AZ)isanm×nmatrix
with the i-th row equal to ft(biX+aiZ).
3.2 The goal of normalization
The statistical goal of microarray analysis is to infer relationships between
biological variables and individual probes or sets of probes. Different
microarray platforms employ different designs. Regardless of the platform,
relevant biological variation can be identiﬁed using individual probes, or
groups of probes that share certain biological characteristics; for example,
probes mapping to the same gene, chromosomal position or pathway. We
use the term ‘probe set’ for any such grouping of probes. We ﬁrst establish
a deﬁnition of a correct normalization when inference is performed on
individual probes (e.g. when there is one probe per gene).
One property that a normalization should satisfy is that E[ bi]=0 when
bi=0 and E[ bi] =0 when bi =0. Stated more directly, the normalization
procedure should preserve the biological relationships of interest in the
expected values of the estimated coefﬁcients corresponding to the biological
variables. A second, less obvious property is that a normalization method
should remove all latent structure shared across probes due to adjustment
variables.Speciﬁcally,anyremainingcomponentoftheaiZ+
rf
t=1ft(biX+
aiZ) term will induce dependence in the error terms across probes, and
unmodeled dependence has been shown to cause large-scale study-speciﬁc
biases (Leek and Storey, 2007, 2008).An imperfect normalization procedure
can bias the bi or induce new sources of latent structure shared across probes
(Dabney and Storey, 2007).
Violation of either of these properties can be seen in the joint distribution
of P-values obtained from testing H0i:bi=0 versus H1i:bi =0. Therefore,
we propose the following criteria as the ideal properties for a normalization
model to achieve.
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Deﬁnition 1. Microarray Normalization Criteria.
(I) The set of ‘null P-values’, obtained from testing H0i:bi =
0 versus H1i:bi =0 for all probes i where bi =0, have a joint
distribution following the Uniform(0,1) distribution.
(II) The set of ‘alternative P-values’ obtained from the above hypothesis
testsforallprobesiwherebi =0haveajointdistributionstochastically
smaller than the Uniform(0,1) distribution.
Correctly normalizing a microarray study is, therefore, a procedure that
preserves the biological relationships of interest and the expected operating
characteristics of the model ﬁts at the probe level. The framework we
introduce in this paper is designed to accomplish this goal, and numerical
evidence we give indicates it does so when all relevant variables have been
measured and included in the model.
We now explain how this deﬁnition relates to probe sets. The central
challenge for inference on probe sets is that technical sources of variation are
very much probe speciﬁc, while biological sources inﬂuence the entire set of
probes.Forexample,intensity-speciﬁceffects,probenucleotidecomposition
and spatial effects are all most appropriately dealt with at the probe level,
while differential expression in response to a treatment is best measured in
terms of its effect across the entire set of probes measuring a given gene.
In our framework, a probe set summarization would combine all bi for
all probes i corresponding to a given probe set, where the bi coefﬁcients
parameterize the biological relationships for each probe.Ageneral probe set
summarization for probe set k that takes this into account is

i:i∈Sk
αibiX,
where the αi have been chosen to represent relative reliability of probe i, the
set Sk is the set of all probe indices in probe set k, and

i∈Sk αi=1. Note
that if bi=0 for all i∈Sk then

i∈Sk αibi=0. In other words, preserving
the proper operating characteristics of  bi for all i also preserves them for 
i∈Sk αi bi (notwithstanding issues with P-value calculations of multiple
variables, which is unrelated to the normalization problem).
Given that this general model for probe summarization lacks terms for
adjustmentvariables,andthatstatisticalinferencewillbecarriedoutonthese
summarized values, the goal for normalization remains the same: namely, to
remove the inﬂuence of adjustment variables on probe intensities in order
to maintain their true relationships with the biological variables of interest.
This is the motivation for formulating the above goal in terms of inference on
probe-leveldata,makingthisgoalrelevantregardlessofmicroarrayplatform,
technology or biological question.
3.3 Supervised normalization of microarrays
Our proposed method, called ‘supervised normalization of microarrays’
(SNM), ﬁts the model from Section 3.1 to all probes and arrays
simultaneously. The big picture idea of the method is to ﬁt a study-speciﬁc
model based on that in (1)–(3) to yield estimates  bi,  ai and  ft. (Note that
there may be more terms in the model to account for other types of effects—
see Supplementary Material.) The ﬁtted model can then be used accordingly
to perform subsequent analyses.
A key feature of SNM is that it involves simultaneously ﬁtting the
biologicalandstudy-speciﬁcadjustmentvariables.Thefactthattheintensity-
dependent effects are functions of terms to be estimated by the model
(i.e. BX+AZ) required us to develop a novel algorithm. The method we
propose attempts to estimate a set of probes that are not associated to the
biological variables (i.e. probes such that bi=0). For ease of discussion,
we call any probe i such that bi=0 a ‘null probe’ and any probe i such
that bi =0 an ‘alternative probe’. Once this set of null probes has been
identiﬁed, we estimate the intensity-dependent effects using only these
probes. Successfully doing so allows us to obtain estimates of the biological
variables’coefﬁcients satisfying the criteria from Section 3.2 . Thus, another
key feature of SNM is that it specially handles the biological variables in
order to obtain valid-ﬁtted model coefﬁcients of these variables.
The following are the main steps of the SNM algorithm; see
Supplementary Material for more details, such as speciﬁcally how we ﬁt
smooth, random functions to model the intensity-dependent effects.
Algorithm Supervised Normalization of Microarrays (SNM)
1. Let w∈{0,1}m be the m-vector indicating our estimate of whether bi=0
(wi=0)orbi =0(wi=1).Weinitiallysetw(0)={0,0,...,0}.Wealsoinitially
set  mij=
n
j=1yij/n and ˆ π
(0)
0 =1, where ˆ π0 is the estimated proportion of
probes where bi=0.
For s=0,1,2,...
2. Fit yi=w
(s)
i biX+aiZ+ei to obtain bi and ai. Set  mij=
d
k=1w
(s)
i  bikxkj+ rc
 =1 ai z j.
3. Let Y0 be the subset of Y composed of rows yi such that w
(s)
i =0. Deﬁne
A0 and  M0 analogously. Fit Y0=A0Z+
rf
t=1ft
 M0

to obtain  A0 and ft.
4. Set Y∗=Y−
rf
t=1 ft
 M

.
5. Fit y∗
i =biX+aiZ+ei and test bi=0 versus bi =0. Use the q-value
methodology (Storey and Tibshirani, 2003) to form ˆ π
(s)
0 , the estimated
proportion of true null probes. For the ˆ π
(s)
0 least signiﬁcant tests, set w
(s+1)
i =
0; set w
(s+1)
i =1 otherwise.
Iterate Steps 2-5 until either |ˆ π
(s+1)
0 −ˆ π
(s)
0 |< or a predetermined number of
steps has been reached.
6.Toperformstatisticalinferenceorprobesetsummarization,adjustthedata
by
y∗
i =yi−
rf 
t=1
 ft
 biX+ aiZ

,
and perform all subsequent inference according to the model
y∗
i =biX+aiZ+ei. (4)
For exploratory analyses, such as clustering or principal components
analysis, adjust the data for probe i by
y∗∗
i =yi− aiZ−
rf 
t=1
 ft
 biX+ aiZ

.
The reason we provide two different types of data adjustments in Step 6 is
that exploratory analyses of the biological signal are best carried out on data
where all signal not of interest has been modeled and removed. However,
for statistical inference, it is necessary to account for the variation explained
and degrees of freedom utilized by the adjustment variables, aiZ. It should
be noted that the model ﬁts we obtain at the ﬁnal iteration of Steps 2–5 are
exactly what would be obtained when ﬁtting model (4) anyway.
4 RESULTS
Unsupervised normalization methods make data transformations
based on graphical trends visible in diagnostic plots. QN (Bolstad
et al., 2003) transforms the data so that a quantile–quantile plot
comparing the ordered probe intensities between any two arrays
in a study is equal to the line y=x (Fig. 1A); ISN (Li and Wong,
2001) transforms the data so that a plot comparing the intensities
of a selected subset of probes between any two arrays is centered
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about the line y=x; and MA-normalization (Dudoit et al., 2002;
Tseng et al., 2001; Yang et al., 2002) transforms the data so that
the relationship between the difference between two groups and
their average value is centered about the line y=0. The implicit
assumption behind each of these unsupervised methods is that
transforming the data to satisfy these criteria removes all variation
due to technical variables, but does not change the signal due
to biological variables. Interestingly, an implicit assumption of
QN is also that the probe intensity distributions among arrays is
always exactly the same, regardless of biology or study design. This
precludes different overall levels and variation of mRNA across
biological conditions, as well as any overall asymmetric differential
expression.
In this section, we demonstrate the operating characteristics
of SNM through simulations and real data analysis, and make
comparisons to the QN and ISN approaches. We also make
comparisons to the eCADS method (Dabney and Storey, 2007),
which is well suited for balanced two group comparisons on
dual-channel arrays and has been shown to outperform the MA-
normalization approach.
4.1 Simulations
While the set of biological and adjustment variables to be utilized
may vary from study to study, we present simulations in the context
of several variables most commonly used: array, batch and dye
effects (Baird et al., 2004; Dabney and Storey, 2007; Wolﬁnger
et al., 2001; Wu and Irrizary, 2007; Wu et al., 2004). For each
type of variable we describe results from data simulations. In the
ﬁrst scenario, we demonstrate how to estimate array effects in the
presence of biological signal. These simulations mimic the most
commonly assumed models for single channel microarray data such
as that provided by Affymetrix. Then, we extend this to a scenario
where we also estimate batch effects, an adjustment variable that
arises in many large microarray datasets, and, as shown below,
can also be present in smaller studies. Finally, we apply SNM
to a scenario based on two-color experiments where the signal is
inﬂuenced by intensity-dependent dye and array effects.
A total of 100 simulated studies were carried out for each of the
three scenarios, with the biological and technical effects simulated
as follows. Data were simulated for a total of 100000 probes and 12
arrays. The biological variable of interest is a dichotomous variable
deﬁning two groups (Groups 1 and 2) with six arrays sampled from
each group. A randomly selected set of 30000 probes were deﬁned
as differentially expressed between two groups, with the magnitude
of the difference sampled from the Normal(1,1) distribution.
To make our simulations as realistic as possible we based our
sampling of baseline probe intensities on data from a commonly
used spike-in study (Irizarry et al., 2003). Speciﬁcally, the baseline
probe intensities were sampled from a distribution consisting of the
mean raw probe intensities for each of the 201800 probes used in
this study.
The random variation terms eij were sampled from a Normal
distribution with mean 0 and a probe-speciﬁc variance term that
was sampled from the Uniform(0.2,0.4) distribution. This implies
that each probe does not have the same variance. The array and
dye functions were deﬁned by randomly selecting coefﬁcients for
a two-dimensional B-spline basis function from a N(0,0.752), the
probe-speciﬁc batch effects were sampled from a N(0,0.42).
Table 1. Results from data simulations
Average ˆ π0 (π0=0.70) No. signiﬁcant KS-tests
Simulations ISN QN SNM eCADS ISN QN SNM eCADS
Array 0.55 0.54 0.75 NA 100 100 1 NA
Array+batch 1.00 1.00 0.74 NA 100 100 4 NA
Array+dye NA NA 0.73 0.72 NA NA 4 1
Shown are the average estimated π0 statistics and the KS-tests of Criterion I. The KS-
tests were performed at the 0.05 level, so we expect 5 of 100 to be signiﬁcant when
Criterion I holds, and many >5 to be signiﬁcant when the criterion does not hold. We do
not include results of testing for Criterion II because all methods passed this criterion
in these simulations.
For the ﬁrst two scenarios, we compare the SNM normalized
data to QN and ISN normalized data. For the third simulation, we
compare the SNM results to those obtained from eCADS. For all
three simulations we use Kolmogorov–Smirnov tests (KS-test) to
assess the validity of each normalization method in terms of the
criteria described in Section 3.2 deﬁning the desired normalization
operating characteristics. To assess Criterion I, we use a two-sided
KS-test to compare the distribution of observed P-values from the
null probes to a Uniform(0,1) distribution. To assess Criterion II,
we use a one-sided KS-test to compare the distributions of P-values
fromthealternativeprobestoaUniform(0,1)distribution.Bothtests
are performed at the 0.05 level, so we expect 5 or less signiﬁcant
tests out of 100 when the criteria are satisﬁed. The results of these
simulations are summarized in Table 1.
4.1.1 Array effects The data were simulated according to the
above protocol where only the biological group differences and
intensity-dependentarrayeffectswereincluded.IntermsoftheSNM
model:Y is a 100000×12 matrix of probe intensities; X i sa1× 12
matrix indicating Group 2 membership; Z i sa1× 12 matrix of 1’s
parameterizing the intercept term; and f(BX+AZ) is a 100000×12
matrixthatrepresentstheintensity-dependentarrayeffects.Notethat
under this construction, we achieve that bi=0 is equivalent to no
difference in mean probe intensities between Groups 1 and 2.
We normalized data from each of the 100 simulations using
SNM, QN and ISN. Figure 2 presents representative histograms of
P-values of null probes after normalization using SNM (Fig. 2A),
QN (Fig. 2C) and ISN (Fig. 2E). In relation to Criterion I, we expect
theseP-valuestobeUniform(0,1).WhiletheSNMapproachappears
to meet this criterion, the null P-values from the unsupervised
methods are clearly not Uniform(0,1). Of the 100 simulated studies,
1, 100 and 100 were signiﬁcant for SNM, QN and ISN, respectively.
Weexaminedtheestimatedπ0 statisticforeachsimulation,which
is the proportion of true null probes (Storey, 2002; Storey and
Tibshirani, 2003). Recall that in this simulation the true π0=70%.
The 95% conﬁdence intervals of ˆ π0 from the 100 simulations are
0.71±0.04 for SNM, 0.54±0.05 for QN and 0.55±0.04 for ISN.
The distributions of all P-values are presented in Figure 2B, D and
F for SNM, QN and ISN, respectively. These results suggest that
including the study-speciﬁc biological variables provides unbiased
inference, while the inference derived from unsupervised methods
is biased by the asymmetric biological signal.
We also performed a KS-test of Criterion II, speciﬁcally whether
the alternative P-values have a joint distribution stochastically
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Fig. 3. Summary of null P-values from simulated data with differential
expression, batch and array effects. The true proportion of null probes is π0
= 0.70. (A) P-value histogram of null probes after the SNM normalization.
(B) P-value histogram of null probes after QN. (C) P-value histogram of
null probes after QN using a model that includes a term for the batch effects.
smallerthantheUniform(0,1)distribution.Amongthe100simulated
studies, 0 tests were signiﬁcant for SNM, QN and ISN.These results
suggest that SNM, QN and ISN satisify Criterion II.
Taken together, these results suggest that SNM satisiﬁes Criteria
I and II for a correctly normalized study in this scenario, while
QN and ISN do not satisfy Criterion I. The bias of QN and ISN
is anti-conservative, meaning that P-values have been spuriously
made smaller than they should be.
4.1.2 Array effects plus batch effects The simulated probe
intensities for the second scenario included biological, array and
batch effects as described above. Batch effects generally arise due
to some need of the experimenter to manufacture or hybridize the
arrays in groups; the real data example we consider below includes
a batch effect. To apply SNM, we used the same model as in the
previoussimulation,exceptnowZisa2×12matrixparameterizing
the probe-speciﬁc intercept terms in the ﬁrst row and an indicator
of batch in the second row.
SNM was applied to normalize data from each of the 100
simulated studies. In the KS-test of Criterion I, 4 out of 100 were
signiﬁcant. The 95% conﬁdence intervals for ˆ π0 was 0.72±0.04.
In the KS-test of Criterion II, 0 out of 100 were signiﬁcant. Thus, it
appearsSNMagainprovidesavalidnormalizationinthissimulation
scenario.
Given that there is an extra study-speciﬁc variable, we applied
QN and ISN in two ways. First, we ignored the batch variable
throughout the analysis. In other words, after normalization, batch
wasnotutilizedasanadjustmentvariablewhentestingtheprobesfor
differentialexpressionbetweenGroups1and2.Ofthe100simulated
studies,all100weresigniﬁcantfortheKS-testofCriterionIforboth
QN and ISN. The 95% conﬁdence intervals for the ˆ π0 were 1±0
for both QN and ISN.
Figure 3B shows a plot of the null probe P-values when applying
QN. (The analogous plot for ISN shows the same qualitative result
and can be found in Supplementary Fig. 1E.) It can be seen that the
null P-values have been biased in a conservative fashion, pushed
towards one. This is due to the fact that ignoring the batch variable
induced systematic variation in the probe intensities that was not
taken into account.
We then applied QN and ISN in a second way, this time including
batch as an adjustment variable in the test of differential expression
after normalization. This would likely be the recommended way to
include the batch variable when utilizing an unsupervised approach.
Speciﬁcally, the unsupervised normalization is carried out ignoring
the batch variable in addition to the biology variable, and then
both are included in the analysis on the normalized data. Of the
100 simulated studies, all 100 were signiﬁcant for the KS-test of
Criterion I for both QN and ISN. The 95% conﬁdence intervals for
the ˆ π0 were 0.52±0.03 for QN and 0.53±0.04 for ISN. Among
the 100 simulations, 0 were signiﬁcant for the criterion II test for all
three normalization methods.
Figure 3C shows a plot of the null probe P-values when applying
QN in this manner. (Again, the analogous plot for ISN shows the
same qualitative result and can be found in Supplementary Fig. 1F.)
Now, the null P-values are anti-conservatively biased; they are
pushedtowardzeroasinthepreviousscenario.Thisfollowsbecause
the systematic variation due to batch has now been modeled at the
inference stage, and the anti-conservative bias due to array effects
has returned. Additionally, since now both the biology and batch
variables were not utilized in the unsupervised normalization, the
null P-value bias and ﬂuctuation from study to study have become
more unpredictable.
4.1.3 Array effects plus dye effects The probe intensities for
the third simulation scenario included biological effects, array
effects and intensity-dependent dye effects as described above.
Dye effects arise in experiments that use two-color microarrays
because of different incorporation rates of the Cy3 and Cy5
ﬂuorescent dyes. To apply SNM, all terms in the model were
deﬁned exactly as in the ﬁrst scenario, except we now deﬁned
f1(BX+AZ)t ob ea1 0 0 0 0 0 ×12 matrix that represents the
intensity-dependent array effects and f2(BX+AZ)t ob ea
100000 × 12 matrix that represents the intensity-dependent dye
effects. The study-speciﬁc model for this case is, therefore,
Y=BX+AZ+f1(BX+AZ)+ f2(BX+AZ)+E.
SNM and eCADS were used to normalize data from each of
the 100 simulated studies. Of the 100 studies, 4 KS-tests were
signiﬁcant for Criterion I when applying SNM and 1 was signiﬁcant
when applying eCADS. The 95% conﬁdence intervals for the ˆ π0
were 0.73±0.03 for SNM and 0.72±0.03 for eCADS. Among the
100 simulations for both SNM and QN, 0 were signiﬁcant for the
Criterion II test. These results show that SNM and eCADS behave
similarly in this scenario, both providing acceptable normalizations.
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Fig. 4. Results from Vascular Development Study obtained from QN and
SNM.The relationship between samples after normalization are presented as
a clustering dendogram. The labels for each node denote the corresponding
age of the sample hybridized to that array, and the colored boxes indicate
the batch. Note that the SNM results correctly position biological replicate
samples on adjacent nodes (A), and predicts a robust effect of age on gene
expression [ˆ π0 = 0.51 (C)]. Conversely, the ﬁrst bifurcation in the QN data
separates the data by the batch (B) and these data suggest there is no effect
of age on gene expression [ˆ π0 =1( D)].
In fact, eCADS can be viewed as a special case of the more general
SNM framework.
4.2 Vascular development study
Astudywascarriedoutdesignedtomeasuretheassociationbetween
gene expression levels and aging in the mouse aorta. Aorta were
micro-dissected from mice aged 1, 7, 14 and 60 days, RNA was
extracted, a single RNA pool was generated for each age, and each
pool was hybridized to a single Affymetrix mouse430 version 2
microarray. This entire experiment was carried out twice, resulting
in two technical batches.
We ﬁrst veriﬁed that there are intensity-dependent array effects
andeffectduetothetwobatches.Tothisend,weregressedageonthe
unnormalized data by for each probe, ignoring batch and intensity-
depdendent effects. On the residuals resulting from this regression,
we investigated the relationship across arrays using hierarchical
clustering (Supplementary Fig. 2A). From this clustering, it can
be seen that there is a strong batch effect in this study. Finally,
the relationship between overall intensity and the array-speciﬁc
residuals were plotted for each array (Supplementary Fig. 2B). This
result shows that there exist non-linear trends between intensity and
the remaining error. Taken together, these results suggest that batch
and intensity-dependent array effects contribute to the variation of
probe level measurements.
Next, we applied SNM to the study. In relation to model (3),
Y is a 450000×8 vector of observed intensities, X parameterizes
the different ages and Z represents the parameterized probe-speciﬁc
intercepts and batch effects. The results when applying SNM are
shown in Figure 4. First, note that the histogram of P-values
(Fig. 4C) suggests that age has a pronounced effect on differential
expression (ˆ π0 =0.53). Many genes with known roles in vascular
biology exhibited robust changes in expression across this time
series, suggesting that the experiment-captured biological signal.
For example, previous work identiﬁed a cluster of seven genes
whose expression is activated soon after birth (List C Elastic Fiber
Genes from McLean et al. 2005). Moreover, the relationship across
samples, as described by a clustering dendrogram, correctly places
the replicate arrays for each age on adjacent nodes (Fig. 4A).
We also investigated the results when these data are normalized
with the two unsupervised normalization procedures considered
above, ISN and QN. The histogram of resulting P-values from
QN is shown in Figure 4D. Results for the ISN method are nearly
identical (as in the simulations) and are not shown here. Note that
both approaches estimate ˆ π0=1, suggesting that there are no genes
differentiallyexpressedbetweenthefouragesexploredinthisstudy.
This result directly contradicts previously published data from a
similar study (McLean et al., 2005) . Moreover, the clustering of the
normalized data, shown in Figure 4B, suggests that batch exhibits
a stronger inﬂuence on the variation of the QN normalized data
than does the biology. This analysis provides a real data example
that supports the results from the data simulations explored earlier,
and the results suggest that the SNM approach outperforms the
unsupervised approaches in this example.
5 DISCUSSION
In this article, we described a framework for the normalization
of microarray data. The central premise of this work is that the
study under investigation should inform the normalization process.
The framework is intended to be general enough to address most
microarray studies, regardless of platform or biological goal. The
examplesweexploredwereselectedastheyarecommonlyoccurring
in practice and clearly describe the effects on inference of ignoring
relevant information from an analysis. We note that the study-
speciﬁc models utilized in this paper will not satisfy all studies.
Rather, we view this work as a general supervised normalization
framework based on a well-deﬁned goal, namely to remove the
effects of adjustment variables without biasing inference, and the
examples as a means to illustrate the beneﬁt of this approach. A
researcher would utilize this framework to build a study-speciﬁc
model and then apply the proposed algorithm, which is quite
general.
The results presented in this paper demonstrate some of the
problems associated with unsupervised normalization methods. For
example, the simulations show how such approaches can introduce
signal in the presence of asymmetric biological variation. Similarly,
the simulations and vascular development example make clear
that unsupervised approaches ignore effects of study design on
expression data. Finally, these approaches make the assumption that
few genes are differentially expressed, an assumption that is clearly
false in many settings. These and other limitations of unsupervised
methods are the motivation for this work.
The framework is designed to handle a variety of study designs.
We presented a modeling strategy that is designed to model
relevant study-speciﬁc variables (e.g. probe-speciﬁc biological
effects, probe-speciﬁc technical effects and intensity-dependent
effects). The ﬂexibility of our modeling strategy is demonstrated
by the fact that it straightforwardly derives previously described
supervised normalization models for more specialized experimental
designs and technologies (Baird et al., 2004; Dabney and Storey,
2007; Wolﬁnger et al., 2001). Another beneﬁt is that other terms
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described in the literature can be included. We describe such a
process for probe sequence effects in the Supplementary Material.
These and other beneﬁts support the claim that we have presented
a ﬂexible set of models for the normalization and analysis of
microarray data.
Model building is paramount to successful implementation of
any supervised normalization, including ours. Properly deﬁning the
model for a given study requires that relevant biological and study-
speciﬁc adjustment variables of interest are known to the analyst, a
situation that is rarely present in the clinical setting. The vascular
development example shows one of many approaches to diagnose
a model from a given dataset. In this work, we focused less on the
difﬁculties associated with this approach; however, future work will
address diagnosing models from the existing data.
Given the potential difﬁculties associated with knowing the true
model, we base our framework on a goal that can be used to
understandthevalidityofastudy-speciﬁcmodel.Theideatoremove
the effects of technical variables without biasing inference has its
roots in ideas originally presented in Dabney and Storey (2007);
Leek and Storey (2007, 2008). To our knowledge, we are the
ﬁrst to explicitly state a goal for microarray data normalization.
Three positive contributions of this goal are: (i) it uniﬁes results
from any particular instance of a study-speciﬁc model; (ii) basing
a normalization algorithm on this goal clariﬁes its purpose and
expected operating characteristics; and (iii) attaining this goal
suggests that the experimenter understands all systematic sources
of variation present in the data. This last point is important as it
allows a user to understand when their assumed model accounts for
variation from all relevant study-speciﬁc variables.
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